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Background: Matrix metalloproteinase (MMPs) are proteins that have a unique role in 
immunity, tissue remodeling, and tumorigenesis. MMPs can break down extracellular 
components, release bioactive molecules, and act on pro-inflammatory cytokines, 
chemokines and other proteins to regulate varied aspects of inflammation and immunity. 
Nicotine (3-(1-methyl-2-pyrrolidinyl) pyridine), a key toxic component of tobacco, is 
thought to dysregulate matrix metalloproteinase secretion in immune cells. Aim: 
Examine the effect of nicotine on MMP9 secretion and activity in primary monocytes. 
Methods: Primary monocytes were stimulated with LPS (1 µg/ml) and Nicotine (100 
ng/ml) and MMP9 secretion were studied. Gel zymography and ELISA techniques were 
used to study the secretion of MMP9 due to nicotine. Furthermore siRNA techniques 
were used to understand the role of the α7 nicotinic acetylcholine receptor (α7nAChR) 
characterize the MMP production. Conclusion: Nicotine decreased the MMP9 activity 
and secretion in primary monocytes. The α7nAChR receptor has an important role in the 
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Tobacco and Disease  
  The World Health Organization in a recent statement reported that tobacco is the 
cause of death for nearly 6 million people per year and unless action is taken the annual 
death toll could rise to more than eight million by 2030 (“WHO Media Center,” 2014) 
The history of tobacco related research started with correlating the use of tobacco with 
disease through epidemiology, then there was a shift in perspective and prevention of 
tobacco use was pursued and recently more studies have begun to pursue the molecular 
correlation to tobacco as an environmental factor of disease. (Wang and Scott 2005) The 
most recent United States Surgeon General report 2010. “How Tobacco Smoke Causes 
Disease.” put emphasis on the biologic mechanisms that make up the pathogenicity of 
tobacco smoke and stressed the importance of finding a biological association with 
previous epidemiological studies. Understanding the molecular basis of tobacco and 
disease leading to various inflammatory process is innovative and could possibly lead to 
therapies that can help prevent disease due to tobacco use.   
 Past epidemiologic studies have shown strong correlation between tobacco use 
and chronic disease (Figure 1.) including heart disease, cancer and microbial infections 
such as bacterial meningitis, periodontitis and post-surgical infections. (Centers for 
Disease Control and Prevention 2010; Bagaitkar 2008)  
  
 2  
 
Figure 1. The health consequences causally linked to smoking. USDHHS 2004, 2006. 
 
 These clinical correlations are very important because they give the base line to 
the biological inquiry. For example, cigarette smokers can have a disruption in 
endothelial cells which can propagate into vascular diseases or accelerate existing 
vascular disease. Mechanisms like decreases in nitrous oxide generation or bioavailability 
and increase in oxidative stress by free radicals are being explored as potential pathways 
for cigarette smoking mediated cardiovascular dysfunction. (Kugiyama et al., 1996) In 
addition, general mechanisms have been proposed for smoker’s susceptibility to 
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pathogenic or opportunistic bacteria. The mechanisms include (i) tobacco-induced 
physiological and structural changes in human smokers, (ii) tobacco-induced increase in 
bacterial virulence and (iii) tobacco-induced dysregulation of immune function. (Wang 
and Scott 2005) These studies bring insight to mechanisms in tobacco induced 
physiological changes by hindering the mucociliary clearance and the dysregulation of 
immune system. Overall, the mechanisms behind tobacco’s ability to cause disease needs 
to be further study so that a better perspective of disease progression can be known. 
 
 Periodontal disease is chronic progressive disease that affects an estimated 22% 
of US adults with mild forms of the disease and 13% with moderate to severe 
disease.(Albandar et al., 1999) Periodontal disease is described as dental plaque, a 
bacterial biofilm, accumulation on teeth near the gingiva causing damage to the gingiva, 
alveolar bone and periodontal ligaments. (Highfield 2009) Clinical symptoms of 
periodontitis are red, swollen gums that may bleed easily. Periodontitis progression 
(Figure 2.) results in the loss of alveolar bone and connective tissue around the tooth 
which is a major cause of tooth loss in adults. Periodontitis has progressive forms starting 
with gingivitis, mild to moderate, and severe periodontitis. They are categorized by the 
clinical attachment loss which is the loss of connective tissue and alveolar bone.  The 
biology behind periodontal disease are pathogenic microorganisms which include 
Porphyrmonas gingivalis, Tannerella forsythesis, and Treponema denticola. (Holt et al., 
2005)  Each of these organisms play a unique role in the disease process of periodontitis 
because each microorganism has specific virulence factors that change the environment 
of the bacterial biofilm.  For example P. gingivalis In addition to pathogenic organisms, 
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genetic and environmental factors such as tobacco contribute to the periodontitis disease 
process. (Reviewed. Pihlstrom et al., 2005) 
 
Figure 2. Periodontal progression as reviewed Baker P.J. 2000 
 A strong correlation is seen between tobacco smokers and periodontal disease. 
Tobacco users have a 5 to 20 fold risk of developing periodontitis that a non-smoker. 
(Bergström 2004) Research has shown that smokers have an increase in susceptibility to 
periodontal disease but a suppression of gingival inflammation and pro-inflammatory 
cytokines. (Scott and Singer, 2004; Palmer et al., 2005 and Johnson and Guthmiller. 
2007) This interesting perspective created a “clinical conundrum” about periodontal 
disease because smoking hides the signs of the infection from the dental professional 
during clinical examination. To further understand the “clinical conundrum” study has 
been lead to review evidence that tobacco smoke may cause (i) acute periodontal 
vasoconstriction, (ii) inhibit periodontal angiogenesis in response to inflammatory 
mediators, and/or (iii) suppress the production of pro-inflammatory mediators. (Scott and 
Singer 2004)  
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 Tobacco contains approximately 4500 constituents that are harmful, toxic and 
potentially carcinogenic. Nicotine (3-(1-methyl-2-pyrrolidinyl) pyridine) is a constituent 
of tobacco known to be the addictive substance (Storr et al., 2004) and plays a unique 
role in tobacco use. Nicotine interacts with nicotinic acetylcholine receptors which 
initially were thought to just be located in the brain but research has shown that the 
receptors are located on additional cells specifically immune cells. (Arias et al., 2009) 
There are currently nine nicotinic acetylcholine receptor subunits. The α7nAChR receptor 
is important because it may have the potential to involve the cholinergic anti-
inflammatory pathway on innate immune cells. Inflammation is a balance between 
systems of the pro-inflammatory system and the anti-inflammatory. Regulation of 
prolonged inflammation is critical to prevent chronic inflammatory diseases such as 
periodontal disease. Our study will explore periodontal disease mechanisms to further the 
body of knowledge of tobacco and disease. 
 
Matrix metalloproteinase (MMPs) are a family of approximately 28 secreted and 
membrane-bound zinc-endopeptidases involved in angiogenesis and tissue remodeling. 
Recent studies show they have a unique role in regulating the release or activation of 
chemokines, cytokines, growth factors, and other bioactive molecules thus participating 
in physiological processes such as innate and adaptive immunity, inflammation, 
angiogenesis, bone remodeling and neurite growth.(Loffek et al., 2011) The activity of 
MMPs is tightly regulated Matrix metalloproteinase at four different levels which are 
gene expression, compartmentalization, pro-enzyme activation and inhibition of 
proteolysis by tissue inhibitors of matrix metalloproteinase (TIMPs). When MMPs are 
 6  
deregulated in knockout mice the mice show susceptibility to skin cancer, impaired 
wound healing in skin, altered inflammatory response in wounds, delay of neutrophil 
infiltration and impaired primary angiogenesis. (Page-McCaw et al., 2007) For example, 
MMP-9 has role in the migration and proliferation of endothelial cells (neo-angiogenesis) 
by releasing vascular endothelial growth factor (VEGF) and tumor necrosis factor (TNF)-
α from the ECM. (Brinckerhoff and Matrisian 2002) If neo-angiogenesis is disturbed it 
has implication in poor wound healing. (Galis et al., 2002) 
Matrix metalloproteinase also have been a therapeutic target in periodontal 
disease with the application of sub-antimicrobial doses of tetracycline because MMP 
increase has been linked with incidence of the periodontal disease. (Gu et al., 2011) 
Periodontal disease in its chronic form is the progressive break down of connective tissue 
and bone and Matrix Metalloproteinase have a direct effect on the ECM and the 
breakdown of tissue. A general mechanism can be described as endotoxin 
(lipopolysaccharide LPS) from the gram-negative periodontal pathogens, induce a local 
accumulation of mononuclear cells and increase pro-inflammatory cytokines and MMPs 
which destruct the periodontal tissues.  
 
  Continuing with the general periodontal disease mechanism; periodontal 
pathogens have LPS-like constituents that immune cells can recognize with their Toll-
like receptors that are located on the cell surface then stimulate the inflammatory 
response, which is observed in the increase of pro-inflammatory cytokines.  Immune cells 
which have been exposed to nicotine and nicotinic byproducts have an altered 
inflammatory response. (Bagaitkar et al., 2012) It is proposed that nicotine 
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inappropriately engages the immune cell’s α7nAChR receptor to regulate the cholinergic 
anti-inflammatory pathway which is used to control the immune overexpression and 
therefore limits the inflammatory response. Cytokines and chemokines in the 
inflammatory response have a unique relationship with the ECM and can be somewhat 
regulated through bioavailability in the ECM so matrix metalloproteinase have a unique 
role in innate immunity. We have recently seen that Matrix Metalloproteinase secretion 
was disrupted by nicotine exposure. (Xu et al., 2008) Current research is limited on the 
novel approach to MMP9 regulation with in the immune system. Therefore, we will 
assess if matrix metalloproteinase 9 is effected by the cholinergic inhibition of the anti-
inflammatory pathway by nicotine when immune cells are exposed to LPS. The role of 
α7nACh receptor in MMP9 production will be studied through pharmacological 
inhibition and siRNA silencing techniques. Matrix metalloproteinase secretion will be 
monitored by enzyme linked immunosorbent assay and gel zymography. Our primary 
model of this pathway is described by Figure 3. 
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Figure 3. α7nAChR dependent anti-inflammatory pathway  




MATERIALS AND METHODS 
 
Materials 
Ultra-pure LPS from Escherichia coli 0111:B4 were purchased from Invivogen. 
(−)-Nicotine was purchased from Sigma-Aldrich Co., St. Louis, MO. α-Bungarotoxin 
was purchased from Tocris Bioscience. α7nAChR antibody (H-302), α7nAChR siRNA 
(h) and scrambled control siRNA were purchased from Santa Cruz Biotechnology, Inc, 
Dallas, Tx. All other Abs were obtained from Cell Signaling Technology. Cytokine 
ELISA kits were purchased from eBioscience.  
  
Cell preparation 
PBMCs were obtained from the venous blood of healthy donors as per protocols 
approved by the University of Louisville, Institutional Review Board, and Human 
Subjects Protection Program. Monocytes were isolated by negative selection using the 
human monocyte isolation kit II from Miltenyi Biotec. The purity of monocytes was 
routinely >90%, as determined by flow cytometry using an FITC-labeled anti-CD14 Ab. 
Monocyte cells were cultured in RPMI 1640 medium supplemented with 10% FBS,        
1 mM sodium pyruvate, 2 mM L-glutamine (Wang, Garcia et al. 2008). 
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Gelatin zymography 
The conditioned growth media were mixed with 4x non-reducing sample buffer 
and resolved at 120 V in 7.5 % sodium dodecylsulphate–polyacrylamide gel 
electrophoresis (SDS–PAGE) gels copolymerized with 1 mg/ml gelatin. The gels were 
then washed with 2.5% Triton X-100 for three 20 min cycles. The gels were then 
incubated in fresh zymogram buffer containing 50 mM Tris (pH 7.5), 3 mM NaN3, 
5 mM CaCl2 and 1 μM ZnCl2 at 37°C overnight and were stained with Coomassie blue to 
visualize the proteolytic bands.  
 
Transfection, cytokine detection, and Western blot 
Transfection of human monocytes were carried out by electroporation using a 4D 
Nucleofector device (Lonza) according to the manufacturer’s protocols. Briefly, purified  
1 × 107 monocytes were resuspended in 100 μl Nucleofector solution (Human Monocytes 
Nucleofector kit; Lonza) and 6 μg siRNA duplexes for each α7nAChR nicotinic receptor 
and scrambled control siRNA duplex. Immediately after electroporation, 1 ml pre 
warmed RPMI growth media containing 10% FBS were added to cells that were then 
transferred into 96 well plate. At 48 h post transfection, cells were exposed to LPS (1 
μg/ml) with or without Nicotine. Cell lysates were prepared using RIPA buffer. For 
siRNA studies, transfected cells were stimulated with LPS (1 μg/ml) and Nicotine (100 
ng/ml), 3 d post transfection, and cell-free supernatants were assayed for cytokine levels 
by ELISA (eBioscience) at 18 h. 
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Western blot 
An equal amount of total protein from primary monocyte resolved in 10% SDS–
PAGE gels at 120 V. The proteins on the gels were transferred to nitrocellulose 
membrane at 0.3 A for 90 min using transfer buffer (25 mM Tris–HCl (pH 8.3), 
192 mM glycine and 10% methanol). The membranes were then incubated in 3% milk in 
tris-buffered solution with 0.1% Tween-20 (TBST, pH 7.4) for 1 h to block nonspecific 
binding. The membranes were then incubated with primary antibodies at 4°C overnight. 
Antibodies used in this study were anti- α7nAChR, anti-GSK3b, anti-MMP-9, and β-
actin. The membranes were then washed three times with TBST and incubated with 
horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. 
Chemiluminescence was detected by an ECL-Plus kit (Thermo Scientific, Pittsburgh, PA) 
and the protein bands were visualized using ImageQuant LAS 4010 (GE Heathcare, 
Pittsburgh, PA).  Densitometric analysis of protein band intensity was performed using 




All data are presented as means ± SEM. Comparison between groups was made 
using one-way ANOVA with the Fisher multiple comparison test. A probability value 
of p < 0.05 was considered statistically significant. All cell culture experiments were 
performed in triplicate on at least three separate occasions. 
 
 






Nicotine Suppresses LPS induced secretion of MMP9 
Primary monocytes were stimulated with LPS (1 µg/ml) and Nicotine (100 ng/ml) 
and MMP9 secretion were studied by ELISA. As shown in figure 3. LPS leads to 
significant increase in MMP9 secretion which is blocked by 100 ng/ml nicotine. Nicotine 






Figure 4. Nicotine suppresses MMP9 secretion. 
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Nicotine suppresses MMP9 secretion α7nAChR dependent manner  
 
To understand the role of α7nAChR in monocyte secretion of MMP9, the cells 
were pretreated with α-bungarotoxin (BTX). α-bungarotoxin known to bind irreversibly 
to α7nAChR thereby preventing nicotine to bind to it. As shown in figure 4, BTX had no 
effect on LPS induced secretion of MMP9 as studied by ELISA but when LPS was added 
to nicotine treated monocytes, nicotine failed to block the effect of LPS on MMP9 
secretion suggesting the role of α7nAChR in secretion of MMP9. Furthermore, to 
establish the role of α7nAChR in secretion of MMP9 in monocytic cells, we used 
knockdown approach using siRNA techniques. First, we established that we could 
significantly knock down the expression of α7nAChR using western blot techniques 
(Figure 5). Thereafter, we studied the effect of nicotine on LPS induced secretion of 
MMP9 in monocytic cells. In the same siRNA treated cells nicotine has lost it ability to 
block the LPS induced secretion of MMP9 in the monocytic cells as quantified by ELISA 
(Figure 6). 
 
 14  
 
 









Figure 5. Nicotine suppresses MMP9 secretion α7nAChR dependent manner 
(pharmaceutical inhibition)  
Figure 6. Silencing of α7nAChR 




  Figure 7. Nicotine suppresses MMP9 secretion α7nAChR 
dependent manner (gene silencing) 
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Nicotine blocks the LPS induced secretion of MMP9 as studied by zymogram 
 We studied the effect of nicotine on LPS induced secretion of MMP9 using 0.1% gelatin 
gel. As evident from the figure 7, the nicotine lead to decrease in active MMP9 activity in 
LPS induced MMP9 secretion in the scrambled control siRNA treated monocytic cells 
but the blocking effect of nicotine on LPS induced secretion of active MMP9 was 





Figure 8. Nicotine suppresses MMP9 secretion α7nAChR 
dependent manner (gene silencing) 






 Matrix metalloproteinases are involved in multiple disease process such as 
impaired wound healing, bone-development defects, and chronic periodontitis. (Vu 1998) 
We are interested in how matrix metalloproteinase regulation relates to periodontal 
disease. Current research shows correlation between oral fluid and MMP9 as a potential 
biomarker for periodontal disease. (Loo et al., 2011; Keles et al., 2006) Periodotitis has a 
close relationship with environmental factor of smoking. Smoking suppresses clinical 
inflammation. In addition, smoking suppresses cytokines. Nicotine reduces pro-
inflammmatory cytokine, which promotes survival of periodontal pathogens that 
encourage disease progression.  
Current research is limited on the novel approach to MMP9 regulation with in the 
immune system. Here we show that Matrix Metalloproteinase are suppressed as well and 
these results are consistent with decreased inflammation/increased disease in smokers. 
Decreased matrix metalloproteinase secretion and activity may help to protect bacteria 
because matrix metalloproteinases release cytokines and chemokines with their 
proteolytic cleavage. Matrix metalloproteinases are involved with angiogenesis and 
wound healing and a suppression of MMP may cause delay in the healing process. 
Nicotine ability to engage the anti-inflammatory pathway and interfere with matrix 
metalloproteinase is novel as well. The anti-inflammatory pathway has been studied in its 
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role in other inflammatory cytokines but to perhaps matrix metalloproteinase 9 into its 
mechanism of action is novel because matrix metalloproteinase is a proteinase and not a 
cytokine or chemokine. Matrix metalloproteinases have the ability to structurally change 
the extracellular matrix to allow for the availablilty of cytokines and chemokines which 
further express the inflammatory response that it is novel that nicotine could possibly be 
interferning with the inflammatory response further upstream by limiting MMP secretion 
so chemokines and cytokines available which leads to the further suppression of 
cytokines. A reduction in pro-inflammmatory cytokines promotes survival of periodontal 
pathogens that encourage disease progression. Therefore, a decrease in secretion of 
matrix metalloproteinase by a primary monocyte exposed to nicotine could further inhibit 
the inflammatory response by restricting chemotaxis. In conclusion, the novel finding of 
nicotine altering the secretion of matrix metalloproteinase will add to current research 
and be an addition to future research. 
Limitations on the proposed model could be that LPS E. coli is a bacteria pathogen that is 
not specifically found in large amounts in the periodontal tissues. When applying the 
model to periodontal disease it may be applicable to involve periodontal pathogens.  
Further research pursuits include characterizing the α7nAChR receptor pathway 
and the TLR pathway role in suppression of matrix metalloproteinase 9 secretion. Studies 
have shown other important signaling molecules down stream to both receptors. (Wang 
2014) These signaling molecules could help to find a more specific control than the 
cholinergic anti-inflammatory pathway that nictone is engaging which then could be used 
as a therapeutic target. Other studies that show promise involve characterzing more of the 
matrix metalloprotienases (there are approximately 20 matrix metalloproteinases) that are 
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involve with the LPS-induced cholinergic inhibition by nicotine. Further matrix 
metalloproteinase study would bring further insight into periodontal disease because 
periodontal disease usually involves a complex amount of matrix metalloproteinase.  The 
model used human monocytes to exhibit the cholinergic inhibition of LPS induction it 
would further aid the research body of knowledge to observe other immune cells such as 
neutrophils. Neutrophils would be of interest because they are more abundant than 
monocytes and are usually first responders to pathogen insults. Neutrophils have a unique 
role in periodontal disease so applying the model to neutrophils would be insightful. 
Finally looking at the activity of matrix metalloprotienases would be intuitive. It has been 
recently shown that a reduction in matrix metalloprotienases activity significantly reduces 
intravascular accumulation and transmigration of immune cells. (Lerchenberger et al 
2013) Further studies that show a reduction in chemotaxis of immune cells or a reduction 
in extracellular matrix breakdown by immune cells when exposed to nicotine would 
further research because nicotine has been associated with a reduction in immunity 
response. Overall, this model was established to further to assess if matrix 
metalloproteinase 9 was effected by the cholinergic inhibition of the anti-inflammatory 
pathway by nicotine when immune cells are exposed to LPS and to bring insight to 
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